Zacks currently has a $16 target price on the stock. Boston Scientific traded up 0.83 percent during mid-day trading on Friday, Feb. 6, hitting $14.57. The stock had a trading volume of 1.4 million shares. The company has a 52-week low of $11.10 and a 52 week-high of $15.28, according to the report.
More articles on GI/endoscopy:
The Children’s Hospital at Montefiore opens pediatric fatty liver disease clinic
Dr. Purvi Panchal joins Pennsylvania Gastroenterology Consultants
Greater Gaston Endoscopy Center officially opens in North Carolina: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.